Antibody Production Market to Generate Revenue Of USD 9.31 Billion With A CAGR Of 13.21% Worldwide By 2029

In 2019, the Antibody Production Market was worth USD 9.12 billion. It is projected to reach USD 9.31 billion by 2029. Between 2020 and 2029, it is expected to grow at 13.21%

The market’s rapid growth can be attributed primarily to the growing demand for therapeutic antibodies (monoclonal and polyclonal) and increased R&D spending by pharmaceutical and biotechnology companies. The Global Antibody Production Market Report provides a comprehensive analysis of this market. This report provides a detailed analysis of market segments, drivers, restraints, competitive environment, and other factors that significantly impact the market.

The COVID-19 pandemic, which has significantly impacted non-communicable diseases care worldwide, has been a severe problem for healthcare globally through 2020. Many medical branches have responded to the lockdowns and sudden restrictions. There is a greater demand for antibodies to treat different diseases. Due to the widespread infection by COVID-19, there has been an increase in chronic and acute diseases. Children and seniors are more at risk of infection than older adults. Fearful of becoming infected, many people resorted to purchasing large quantities of antibodies on the black marketplace to avoid unnecessary hospitalizations. These factors will likely increase the growth of the global antibody production industry over the forecast period.

Get a report sample to get a comprehensive insight @ https://market.us/report/antibody-production-market/request-sample/

Driving Factors:

North America will hold the most significant global antibody production market share during the forecast period. This is due to America’s high-quality healthcare infrastructure and the increasing prevalence of chronic diseases. These are the key drivers of market growth. The market is also experiencing rapid growth due to the increasing number of mAbs available that can be used to treat cancer and other diseases.

Restraining Factors:

Cancer treatment is more expensive

High chemotherapy costs are the most significant problem facing the antibody production market. Their prices are increasing in line with their growing success rate. Many cannot afford to pay for drugs that treat cancer. Even the most wealthy cannot afford to pay for these expensive treatments, even if they aren’t in the middle of the poverty line. Medication costs can easily exceed many people’s monthly income. Markets are being held back due to the rising costs of cancer diagnosis and treatment in low-income countries. Patients are more likely than ever to opt for low-cost diagnostic methods, which decreases the number of patients who need them.

Market Key Trends:

The global antibody production Market will grow due to rising incidences of infectious diseases and increased demand for protein therapeutics. Monoclonal antibody’s clinical and commercial success has led to the need for large-scale monoclonal antibody production in mammalian cell culture. Biotechnology and pharmaceutical companies are now focusing on developing new antibodies for chronic diseases such as arthritis, rheumatism, heart disease, and rheumatism. The imminent expiry of patents on many blockbuster monoclonal antibody products is another critical factor in expanding the market for antibody production. The U.S. patents on Herceptin (trastuzumab) expire in June 2019.

Recent development:

The National Institute of Health of America (NIH), launched a clinical trial testing a monoclonal antibody dupilumab in June 2022. This could reduce asthma attacks and improve symptoms for children living in low-income urban areas with poorly controlled allergies.
Roche launched Phesgo in May 2022. The combination of Perjeta (pertuzumab), Herceptin, and Hyaluronidase was created to treat metastatic HER2-positive early breast cancers in India.

Key Market Players:

Thermo Fisher Scientific#Inc.
GE Healthcare
Sartorius AG
Merck KGaA
Eppendorf AG
Cellab GmbH
Pall Corp.
INTEGRA Biosciences AG
FiberCell Systems Inc.

Key Market Segments:

Type:
Polyclonal antibody
Monoclonal antibody
Murine
Chimeric
Humanized

Application:
Companies in pharmaceutical and biotechnology
Research labs
Other

For inquiry, click [email protected]: https://market.us/report/antibody-production-market/#inquiry

Frequently Asked Questions (FAQs):

What will be the market size and growth rate of the Antibody Production Market in the future?
What are the key factors driving the growth of the Antibody Production Market?
Which region was the Antibody Production Market largest represented?
What are the top players in Antibody Produce Market Market?

Check out our Demanding and Trending Reports.

Global Active Pharmaceutical Ingredients market Production Sales and Consumption Status Report 2022-2031
Global Single Use Bioprocessing MarketGrowth and Production, Production Value, & Forecast 2022-2031
Analysis of the Global Downstream Processing Market Industry Share, Growth Trends, And Forecast 2022-2031
Global Lyophilized Injectable Drugs Market Statistics, Facts And Figures, Size, Share, Trends And Forecast 2022 – 2031
Global Antibodies Market Growth And Forecast Research 2022

About Market.us

Market.US (Powered by Prudour Private Limited) specializes in market research and analysis. It has proven its worth as a consulting and custom market research company. They are also a highly sought-after syndicated report provider firm.

Contact Details:

Global Business Development Team Market.us
Address: 420 Lexington Avenue, Suite 300 New York City, NY 10170, United States
Phone: +1 718 618 4351 (International), Phone: +91 78878 22626 (Asia)
Email: [email protected]


Leave a Reply

Your email address will not be published. Required fields are marked *